Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study
✍ Scribed by Xiang Yang Zhang; Dong Feng Zhou; Lian Yuan Cao; Pei Yan Zhang; Gui Ying Wu; Yu Cun Shen
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 110 KB
- Volume
- 178
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Risperidone is a widely used agent as first‐line treatment in schizophrenia with a favorable side‐effect profile. However, a number of case reports have suggested an increase in obsessive–compulsive symptoms in patients treated with risperidone. ## Objective The aim of
## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W